PIK3CA c.196T>G ;(p.S66A)

Variant ID: 3-178916809-T-G

NM_006218.2(PIK3CA):c.196T>G;(p.S66A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines.

Oncotarget
Grant, Trevor J TJ; Mehta, Anita K AK; Gupta, Anamika A; Sharif, Ahmad A D AAD; Arora, Kshitij S KS; Deshpande, Vikram V; Ting, David T DT; Bardeesy, Nabeel N; Ganem, Neil J NJ; Hergovich, Alexander A; Singh, Anurag A
Publication Date: 2017-10-03

Variant appearance in text: PI3K: S66A
PubMed Link: 29108249
Variant Present in the following documents:
  • Main text
  • oncotarget-08-78556.pdf
View BVdb publication page



The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.

The Journal Of Biological Chemistry
Huang, Wei W; Lv, Xianbo X; Liu, Chenying C; Zha, Zhengyu Z; Zhang, Heng H; Jiang, Ying Y; Xiong, Yue Y; Lei, Qun-Ying QY; Guan, Kun-Liang KL
Publication Date: 2012-07-27

Variant appearance in text: PI3K: S66A
PubMed Link: 22692215
Variant Present in the following documents:
  • Main text
View BVdb publication page